Key points
- •
Early diagnosis of hearing loss with a combination of electrophysiological and behavioral test measures is critical in initiating treatment during a period of maximal neural plasticity.
- •
Medical assessment involves history, examination, imaging, and other testing to identify a possible cause, allow counseling regarding risk of progression of hearing loss and potentially modifiable factors, and search for anatomic factors that can adversely affect prognosis using a cochlear implant (CI).
- •
Early fitting with hearing aids (HAs) before 3 months of age and commencement of an early intervention program by 6 months is recommended by the Joint Commission on Infant Hearing.
- •
If auditory-verbal communication is the aim, HAs are rarely sufficient in this population. Therefore, CIs are the mainstay of care. Implanting should ideally occur at or before 12 months of age to maximize speech and language outcomes.
- •
When expected outcomes are not achieved, possible causes of underperformance or regression may be related to pathologic or surgical electrode-neural interface problems, patient factors, audiologic-habilitative issues, or device issue.
ABR | Auditory brainstem response |
ANSD | Auditory neuropathy spectrum disorder |
ASSR | Auditory steady state response |
CI | Cochlear implant |
CM | Cochlear microphonic |
CMV | Cytomegalovirus |
CND | Cochlear nerve deficiency |
FDA | United States Food and Drug Administration |
HA | Hearing aid |
HRCT | High-resolution computed tomography |
OAE | Otoacoustic emissions |
SNHL | Sensorineural hearing loss |
Overview: nature of the problem
Severe hearing loss is defined as a pure tone threshold of 71 to 90 dB on hearing level audiogram, whereas profound hearing loss is defined as a pure tone threshold of greater than 90 dB. Approximately 4000 children are born each year in the United States with bilateral severe to profound sensorineural hearing loss (SNHL), which constitutes about one-third to one-fourth of those born with any form of unilateral or bilateral SNHL. In the United Kingdom, the prevalence of children born with any kind of permanent hearing loss is approximately 1 in 1000, with a prevalence of 0.3 in 1000 diagnosed with severe hearing loss and 0.3 in 1000 diagnosed with profound hearing loss. In the United States, these numbers are slightly higher with 3 to 4 per 1000 births with permanent hearing loss and 1 in 1000 with profound hearing loss.
The management of children with severe to profound and profound SNHL is dominated by the need to provide sufficient audibility as well as temporal and spectral resolution capabilities to support expressive and receptive language development. Although hearing aids (HAs) can provide some of the needed information, they are often not sufficient for spoken language development so a cochlear implant (CI) is chosen. Equally important is that auditory information provided by the CI is introduced during a period of sufficient neural plasticity to allow the signal to be integrated into the central pathways and allow connection between the presence of sound and its meaning.
Overview: nature of the problem
Severe hearing loss is defined as a pure tone threshold of 71 to 90 dB on hearing level audiogram, whereas profound hearing loss is defined as a pure tone threshold of greater than 90 dB. Approximately 4000 children are born each year in the United States with bilateral severe to profound sensorineural hearing loss (SNHL), which constitutes about one-third to one-fourth of those born with any form of unilateral or bilateral SNHL. In the United Kingdom, the prevalence of children born with any kind of permanent hearing loss is approximately 1 in 1000, with a prevalence of 0.3 in 1000 diagnosed with severe hearing loss and 0.3 in 1000 diagnosed with profound hearing loss. In the United States, these numbers are slightly higher with 3 to 4 per 1000 births with permanent hearing loss and 1 in 1000 with profound hearing loss.
The management of children with severe to profound and profound SNHL is dominated by the need to provide sufficient audibility as well as temporal and spectral resolution capabilities to support expressive and receptive language development. Although hearing aids (HAs) can provide some of the needed information, they are often not sufficient for spoken language development so a cochlear implant (CI) is chosen. Equally important is that auditory information provided by the CI is introduced during a period of sufficient neural plasticity to allow the signal to be integrated into the central pathways and allow connection between the presence of sound and its meaning.
Patient evaluation overview
Assessment to confirm the degree of hearing loss and identify the cause should be carried out as early as is feasible to allow treatment to occur within an appropriate time frame. Ideally, this process begins immediately following the failure result on a newborn infant hearing screening examination or when family members begin to suspect a lack of sound awareness by the child. The management paradigm of such an infant combines formal diagnostic testing of auditory capabilities with a search for a cause and associated medical disorders, education of the family about options for achieving good communication skills, and medical or surgical intervention, all within the first year of life. This requires a multidisciplinary approach combining the skills of audiologists, speech pathologists, otolaryngologists, pediatricians, genetic counselors, and early intervention programs, while encouraging the family to be active participants in the health care team (ie, family-centered care). For those with progressive loss that becomes severe to profound in the prelingual period, a similar time frame for evaluation and treatment is ideal. Although postlingual children may not carry the same burden of expediency from a speech and language perspective, a prolonged period of auditory deprivation reduces the child’s access to learning opportunities and potentially reduces the efficacy of intervention later on.
Medical Assessment
- •
History and physical examination should assess
- ○
The onset, degree, progression, and developmental impact of hearing loss, particularly as it relates to the duration of deafness
- ○
Risk factors for hearing loss, including perinatal illnesses, prematurity, hypoxia, jaundice, need for neonatal intensive care or intubation, meningitis, exposures to ototoxic drugs, head injury, and family history of hearing loss
- ○
Other health problems that may preclude or increase the risk of a general anesthetic or may assist in determining if a syndrome is present
- ○
Other developmental milestones, particularly evidence of cognitive deficits
- ○
Physical signs of syndromic features, craniofacial anomalies, conductive hearing loss, or otitis media.
- ○
Audiologic Assessment
To allow early determination of the presence and degree of hearing loss, electrophysiological measures are used when behavioral measures are inappropriate or inaccurate. This should take the form of newborn hearing screening soon after birth, followed by some combination of frequency-specific auditory brainstem response (ABR) testing, auditory steady-state response (ASSR) testing, otoacoustic emission (OAE), and tympanometry. Each test has unique characteristics and a combination of some or all of these are usually required to give the most comprehensive picture of the child’s auditory capabilities, including the severity and site of hearing loss. For the population of children with severe to profound SNHL, this early assessment aids in forming an estimate of amplification requirements, mobilization of the care team for close observation of the child’s progress, as well as early planning for possible future interventions, thus avoiding treatment delays.
In almost all cases, electrophysiological testing is sufficient to estimate the hearing levels for the purpose of fitting conventional amplification. Importantly, however, such testing methods may have some unique challenges that are critical in managing children with SNHL. Although OAEs are generally absent in children with severe to profound hearing loss, they can be present in children with auditory neuropathy spectrum disorder (ANSD). ANSD affects 10% to 14% of newly diagnosed children with severe to profound bilateral SNHL. These test results, taken in isolation, can inappropriately suggest less severe hearing loss. Similarly, the unique ABR waveforms seen in ANSD often require an experienced clinician to detect. Typically, the cochlear microphonic (CM) waveform is present with absent or abnormal ABR waveforms. The CM waveform is distinguished from artifact by demonstration of inversion of the response with inversion of the signal polarity stimulus ( Fig. 1 ). Thus, identification of the CM waveform requires a protocol that includes both rarefaction and condensation stimuli. The CM waveform is further distinguished from artifact by a loss of response when disconnecting the sound tubing. The ANSD phenotype is not diagnosable on ASSR so ABR is needed to make this diagnosis. Tympanometry can support bone conduction ABR testing and clinical examination in the identification of a conductive component to the hearing loss.
Behavioral testing using visual reinforcement audiometry can accurately confirm the severity of hearing loss in children around 6 to 8 months of age. Behavioral thresholds are particularly important in children with ANSD because the ABR is unable to determine hearing thresholds for fitting amplification. This kind of testing can be challenging in children with severe to profound SNHL due to their lack of familiarity with sound. Those with concurrent global developmental delay can also have less consistent conditioned behavioral responses.
Imaging
Imaging is critical in children with significant hearing loss because it can aid in identifying a cause, possibly predict hearing loss progression, and potentially identify those with a poor prognosis for speech development using HAs or CIs. Imaging can take the form of MRI with or without high-resolution computed tomography (HRCT) of the temporal bone structures and brain. Imaging allows anatomic assessment of the labyrinth, cochlea, cochleovestibular, and facial nerves. It also identifies concurrent brain disease. A diagnosis of cochlear nerve deficiency (CND) or significant cochlear or labyrinthine abnormalities may either preclude the use of a CI or predict a low chance of achieving open-set speech perception.
CND is present in approximately 1% of children with bilateral SNHL, most often in the setting of severe to profound thresholds. Labyrinthine abnormalities have been detected in up to 40% of children with SNHL and can range in severity. Identification of both CND and inner ear malformations allows the treating team to provide realistic expectations to families about outcomes with the various interventions and to maximize communication by augmenting auditory-verbal communication with nonauditory forms. Detecting abnormalities of the facial nerve can help guide safe CI surgery, particularly in the setting of semicircular canal abnormalities ( Fig. 2 ).
High-resolution MRI with a 3-dimensional Fourier transformation constructive interference steady-state protocol is the most sensitive for diagnosing CND and has the unique ability to assess for concurrent brain disease, which may be present in up to 40% of pediatric CI recipients. HRCT is complementary for assessing labyrinthine anomalies ( Fig. 3 ), other temporal bone disease, and the presence and pathway of the fallopian canal. One shortcoming of HRCT as a single imaging modality is that it cannot identify CND in the setting of a normal caliber internal auditory canal. Both MRI and HRCT are important in assessing cochlear patency in children suffering from hearing loss secondary to meningitis ( Fig. 4 ).
Other Common Testing
These tests may be useful in identifying the cause of the hearing loss and risk of transmission to future off spring, associated medical conditions that may require early treatment, and potential prognosis for progression of hearing loss and performance with CIs:
- •
Electrocardiogram (Jervell and Lange-Nielsen syndrome)
- •
Cytomegalovirus (CMV) testing of urine and Guthrie card
- •
Connexin 26 and 30 gene sequencing and other genetic testing
- •
Urinalysis (Alport syndrome in older children)
- •
Retinal examination and visual acuity testing (Usher’s syndrome)
- •
Renal ultrasound in children with branchial anomalies (branchio-oto-renal syndrome)
- •
Investigations for concurrent medical conditions as the history and examination indicate
- •
Comprehensive, molecular genetic testing.
Management goals
Overall, the aim of management in children with severe to profound SNHL is to either introduce adequate sound for the purposes of auditory-verbal speech and language development or teach the child and caregivers alternative communication strategies. Irrespective of approach, intervention should ideally be undertaken as soon as is medically feasible to optimize outcomes.
Communication Options and Intervention
Communication options for children with severe, severe to profound, and profound hearing loss include verbal and nonverbal strategies (ie, sign language). Although nonauditory approaches to verbal communication through lipreading were commonplace in the past, auditory approaches have become more common in recent times, owing to better outcomes. Auditory supplementation through amplification when possible or cochlear implantation allows for improved sound awareness, enhanced lipreading, speech understanding, and vocal control. These are the underpinnings for optimal auditory-oral communication development.
As a matter of ethical and moral obligation to these children, appropriate resources should be made available for learning about verbal and nonverbal communication strategies. Auditory-oral communication supplemented through amplification and/or cochlear implantation results in the highest levels of educational achievement and employment opportunities for hard-of-hearing and deaf children. Importantly, informed parental choice remains the single most important determinant in such decisions because self-determination is not possible at such an early age. To advocate for a delayed choice at this early age is, by default, a decision for nonverbal communication because delayed intervention, beyond the critical period for speech and language development in the brain, rarely results in age-appropriate auditory-verbal skills. Because 95% of hard-of-hearing and deaf children are born to 2 hearing parents, auditory-oral communication is the dominant choice because this represents a more familiar strategy for these families.
For families that choose to pursue auditory-oral communication for their child, a referral to an appropriate early intervention specialist, and fitting of HAs by a pediatric audiologist should be carried out as early as possible to maximize each child’s access to sound. The Joint Committee on Infant Hearing recommends that HA fitting occur before 3 months of age and that an early intervention program is in place by 6 months of age. It is critical that each child be closely observed for speech and language progress by a variety of well-trained professionals (audiologists, speech-language pathologists, pediatricians, and otolaryngologists). By necessity, this patient population requires high-gain amplification with resulting issues of feedback, distortion, cerumen impaction, and occasionally otitis externa. Additionally, otitis media can be problematic in this age group and can add conductive hearing loss to the underling SNHL. Close collaboration between the treating audiologist and otolaryngologist is needed to minimize the impact of these medical issues. If a given child is making adequate progress with HAs alone, then continued close observation is appropriate. In most instances, children with severe to profound SNHL do not make age-appropriate gains despite correctly fitted amplification. In such cases, cochlear implantation should be considered to achieve auditory-verbal language.